The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Aug. 26, 2025
Filed:
Nov. 27, 2023
Applicant:
Pulmonem Inc., Dieppe, CA;
Inventors:
Houfar Sekhavat, Dieppe, CA;
Satish Asotra, Brampton, CA;
Assignee:
PULMONEM INC., Dieppe, CA;
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/145 (2006.01); A61K 9/00 (2006.01); A61K 9/06 (2006.01); A61K 9/14 (2006.01); A61K 31/10 (2006.01); A61K 31/65 (2006.01); A61K 31/7052 (2006.01); A61K 47/14 (2017.01); A61K 47/42 (2017.01); A61K 47/44 (2017.01); A61M 15/00 (2006.01); A61P 11/00 (2006.01);
U.S. Cl.
CPC ...
A61K 31/145 (2013.01); A61K 9/0043 (2013.01); A61K 9/0075 (2013.01); A61K 9/06 (2013.01); A61K 9/14 (2013.01); A61K 31/10 (2013.01); A61K 31/65 (2013.01); A61K 31/7052 (2013.01); A61K 47/14 (2013.01); A61K 47/42 (2013.01); A61K 47/44 (2013.01); A61M 15/0028 (2013.01); A61M 15/0065 (2013.01); A61P 11/00 (2018.01); A61M 2202/064 (2013.01);
Abstract
A method for treating patients with COVID-19 and/or other respiratory conditions includes administering eighty-five milligrams of dapsone twice daily for twenty-one days. A variety of dapsone formulations and delivery devices are disclosed, including an inhaler, nasal spray, nasal gel, otic formulation, intravenous formulation, oral solution, oral suspension, patch and suppository.